I don't know enough to comment on that twitter post.
The CDTX management team is made up of some ex-Trius executives who worked on Tedizolid (now marketed by Merck under the name Sivextro). So their management has a lot of credible experience, IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.